Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Chiara Garassino

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Cancer Immunology Research|January 16, 2021
At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for CancerMarina Chiara Garassino, Antoni Ribas
Cell Metabolism|June 6, 2019
Membrane Cholesterol Regulates Macrophage Plasticity in CancerAntonio Sica, Augusto Bleve, Marina Chiara Garassino
Cancer Management and Research|February 5, 2013
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancerMassimo Broggini, Marina Chiara Garassino, Giovanna Damia
Cancer|June 23, 2009
Predictive models in palliative careCarla Ida Ripamonti, Gabriella Farina, Marina Chiara Garassino
Translational Lung Cancer Research|March 10, 2016
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?Giuseppe Lo Russo, Claudia Proto, Marina Chiara Garassino
Tumori|March 17, 2016
Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yetGiuseppe Lo Russo, Martina Imbimbo, Marina Chiara Garassino
Lung Cancer (Amsterdam, Netherlands)|June 17, 2022
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapiesMelissa Johnson, Marina Chiara Garassino, Tony Mok, et al.
World Journal of Clinical Oncology|October 16, 2015
New findings on thymic epithelial tumors: Something is changingRossana Berardi, Francesca Morgese, Marina Chiara Garassino, et al.
Cancer Research|October 17, 2018
Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition ActivityMarina Chiara Garassino, Valter Torri, Mario Paolo Colombo, et al.
Cancer Treatment Reviews|October 12, 2013
The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancersAntonio Rossi, Valter Torri, Marina Chiara Garassino, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Cancer Immunology Research|January 16, 2021
At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for CancerMarina Chiara Garassino, Antoni Ribas
Cell Metabolism|June 6, 2019
Membrane Cholesterol Regulates Macrophage Plasticity in CancerAntonio Sica, Augusto Bleve, Marina Chiara Garassino
Cancer Management and Research|February 5, 2013
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancerMassimo Broggini, Marina Chiara Garassino, Giovanna Damia
Cancer|June 23, 2009
Predictive models in palliative careCarla Ida Ripamonti, Gabriella Farina, Marina Chiara Garassino
Translational Lung Cancer Research|March 10, 2016
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?Giuseppe Lo Russo, Claudia Proto, Marina Chiara Garassino
Tumori|March 17, 2016
Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yetGiuseppe Lo Russo, Martina Imbimbo, Marina Chiara Garassino
Lung Cancer (Amsterdam, Netherlands)|June 17, 2022
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapiesMelissa Johnson, Marina Chiara Garassino, Tony Mok, et al.
World Journal of Clinical Oncology|October 16, 2015
New findings on thymic epithelial tumors: Something is changingRossana Berardi, Francesca Morgese, Marina Chiara Garassino, et al.
Cancer Research|October 17, 2018
Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition ActivityMarina Chiara Garassino, Valter Torri, Mario Paolo Colombo, et al.
Cancer Treatment Reviews|October 12, 2013
The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancersAntonio Rossi, Valter Torri, Marina Chiara Garassino, et al.
Pageof 17